Dividends Inside 
Korro Bio, Inc.
KKR
$89.00 (+ $2.00 + 2.30%)
Last updated: 2026-10-20 16:47 UTC
Korro Bio, Inc. trades under ticker KKR on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Financial Services exposure. Identifiers: ISIN US48251W1045, CUSIP 48251W104. Also searched as Korro Bio.
Related researchKKR stock priceKKR share priceKKR dividend historyKKR dividend yieldKorro Bio dividend historyKorro Bio dividend yield48251W104Korro Bio stockKorro Bio share price
About the Company
Korro Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines for rare and more common diseases. The company’s programs are designed to make precise changes at the RNA level, aiming to address disease-causing biology without permanently altering DNA. Its current pipeline includes lead candidate KRRO-121, a GalNAc-conjugated RNA editing oligonucleotide under development for hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy, along with additional research programs in liver and other therapeutic areas. Korro Bio’s platform is built around programmable RNA editing and oligonucleotide-based delivery, positioning the company within the growing field of next-generation genetic medicines. Based in Cambridge, Massachusetts, Korro Bio focuses on discovery and development activities across its research and clinical-stage portfolio.